Home/Filings/4/0000905148-25-003507
4//SEC Filing

Mirza Mansoor Raza 4

Accession 0000905148-25-003507

CIK 0001781174other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:28 PM ET

Size

5.2 KB

Accession

0000905148-25-003507

Insider Transaction Report

Form 4
Period: 2025-10-01
Mirza Mansoor Raza
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-10-01+225,000225,000 total
    Exercise: $1.81Exp: 2035-09-30Common Stock (225,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vest on November 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Documents

1 file

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1
  • filerCIK 0001588389

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:28 PM ET
Size
5.2 KB